|
|
Volumn 29, Issue 5, 1997, Pages 2461-2466
|
|
Immunosuppressive drugs and pregnancy: Experimental and clinical data
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B;
ANTICONVULSIVE AGENT;
ANTIHYPERTENSIVE AGENT;
AZATHIOPRINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CIMETIDINE;
CLONIDINE;
CORTICOSTEROID;
CYCLOSPORIN A;
DIGITALIS;
DIHYDRALAZINE;
DIURETIC AGENT;
FLUCONAZOLE;
IMMUNOSUPPRESSIVE AGENT;
ITRACONAZOLE;
KETOCONAZOLE;
MACROLIDE;
METHYLDOPA;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID;
NICARDIPINE;
OKT 3;
PRAZOSIN;
PREDNISONE;
RAPAMYCIN;
RILMENIDINE;
TACROLIMUS;
UNINDEXED DRUG;
VASODILATOR AGENT;
ANIMAL MODEL;
CARCINOGENICITY;
CONFERENCE PAPER;
FETUS;
FETUS DISEASE;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAUTERINE GROWTH RETARDATION;
INTRAVENOUS DRUG ADMINISTRATION;
MATERNAL DISEASE;
MATERNAL HYPERTENSION;
MUTAGENICITY;
NONHUMAN;
PREGNANCY;
PREMATURITY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
TERATOGENICITY;
TREATMENT INDICATION;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ORGAN TRANSPLANTATION;
PREGNANCY;
|
|
EID: 0030772353
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(97)00450-8 Document Type: Conference Paper |
|
Times cited : (23)
|
|
References (14)
|
